{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:31:50Z","timestamp":1793820710444,"version":"4.6.1"},"reference-count":203,"publisher":"Bentham Science Publishers Ltd.","issue":"5","funder":[{"DOI":"10.13039\/501100004705","name":"King Mongkut\u2019s University of Technology Thonburi, KMUTT","doi-asserted-by":"publisher","award":["12\/2561"],"award-info":[{"award-number":["12\/2561"]}],"id":[{"id":"10.13039\/501100004705","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>Recombinant active peptides are utilized as diagnostic and biotherapeutics in various maladies and as bacterial growth inhibitors in the food industry. This consequently stimulated the need for recombinant peptides' production, which resulted in about 19 approved biotech peptides of 1-100 amino acids commercially available. While most peptides have been produced by chemical synthesis, the production of lengthy and complicated peptides comprising natural amino acids has been problematic with low quantity. Recombinant peptide production has become very vital, cost-effective, simple, environmentally friendly with satisfactory yields. Several reviews have focused on discussing expression systems, advantages, disadvantages, and alternatives strategies. Additionally, the information on the antimicrobial activities and other functions of multiple recombinant peptides is challenging to access and is scattered in literature apart from the food and drug administration (FDA) approved ones. From the reports that come to our knowledge, there is no existing review that offers substantial information on recombinant active peptides developed by researchers and their functions. This review provides an overview of some successfully produced recombinant active peptides of \u2264100 amino acids by focusing on their antibacterial, antifungal, antiviral, anticancer, antioxidant, antimalarial, and immune-modulatory functions. It also elucidates their modes of expression that could be adopted and applied in future investigations. We expect that the knowledge available in this review would help researchers involved in recombinant active peptide development for therapeutic uses and other applications.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389201022666210702123934","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T09:03:46Z","timestamp":1625562226000},"page":"645-663","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Recombinant Active Peptides and their Therapeutic Functions"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9691-4194","authenticated-orcid":true,"given":"Ya\u2019u Sabo","family":"Ajingi","sequence":"first","affiliation":[{"name":"Department of Microbiology, Faculty of Science, King Mongkut\u2019s University of Technology Thonburi (KMUTT), Bangkok, Thailand | Department of Biology, Faculty of Science, Kano University of Science and Technology (KUST), Wudil, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0235-3622","authenticated-orcid":true,"given":"Neeranuch","family":"Rukying","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Science, King Mongkut\u2019s University of Technology Thonburi (KMUTT), Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7946-960X","authenticated-orcid":true,"given":"Aiyada","family":"Aroonsri","sequence":"additional","affiliation":[{"name":"National Center for Genetic Engineering and Biotechnology (BIOTEC), Pathum Thani, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8839-2568","authenticated-orcid":true,"given":"Nujarin","family":"Jongruja","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Science, King Mongkut\u2019s University of Technology Thonburi (KMUTT), Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fchem.2014.00062","volume":"2","author":"Otvos L.","year":"2014","unstructured":"Otvos L.; Wade J.D.; Current challenges in peptide-based drug discovery. Front Chem 2014,2,8-11","journal-title":"Front Chem"},{"key":"ref=2","first-page":"46","volume":"2010","author":"Analysis A.","year":"2008","unstructured":"Analysis A.; Development trends for peptide therapeutics. Development 2008,2010,46","journal-title":"Development"},{"key":"ref=3","first-page":"10","author":"Lax R.","year":"2010","unstructured":"Lax R.; The future of peptide development in the pharmaceutical industry PharManufact 2010,10-15","journal-title":"The future of peptide development in the pharmaceutical industry PharManufact"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00726-017-2516-0","volume":"50","author":"Jaradat D.M.M.","year":"2018","unstructured":"Jaradat D.M.M.; Thirteen decades of peptide synthesis: Key developments in solid phase peptide synthesis and amide bond formation utilized in peptide ligation. Amino Acids 2018,50(1),39-68","journal-title":"Amino Acids"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"10030","DOI":"10.1002\/anie.200801313","volume":"47","author":"Hackenberger C.P.R.","year":"2008","unstructured":"Hackenberger C.P.R.; Schwarzer D.; Chemoselective ligation and modification strategies for peptides and proteins. Angew Chem Int Ed 2008,47(52),10030-10074","journal-title":"Angew Chem Int Ed"},{"key":"ref=6","author":"Funfrock P.","unstructured":"Funfrock P.; Challenges in chemical and recombinant peptide production processesAvailable from: https:\/\/www.proteogenix.science [Accessed May 6, 2020]","journal-title":"Challenges in chemical and recombinant peptide production processesAvailable from:"},{"key":"ref=7","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-774-2:015","author":"Palomares L.A.","unstructured":"Palomares L.A.; Estrada-Mondaca S.; Ram&#xED;rez O. T.; Production of recombinant proteins: Challenges and solutions Recomb Gene Expr, 2004, 267, 015-052","journal-title":"Production of recombinant proteins: Challenges and solutions Recomb Gene Expr, 2004, 267, 015-052"},{"key":"ref=8","unstructured":"ClinicalTrials drug approvals: Are more likely to be approved as pipeline recombiantAvailable from: https:\/\/www.clinicaltrialsarena.com\/comment\/synthetic-peptide-drugs-less-likely-to-be-approved-than-recombinant-peptide-drugs\/[Accessed Sep 9, 2020]","journal-title":"ClinicalTrials drug approvals: Are more likely to be approved as pipeline recombiantAvailable from:"},{"key":"ref=9","unstructured":"US food https:\/\/www.fda.gov\/drugs\/regulatory-science-action\/impact-story-developing-tools-evaluate-complex-drug-products-peptides [Accessed Sep 9, 2020]","journal-title":"US food"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","volume":"26","author":"Lau J.L.","year":"2018","unstructured":"Lau J.L.; Dunn M.K.; Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorg Med Chem 2018,26(10),2700-2707","journal-title":"Bioorg Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2174\/138527281808140616160013","volume":"18","author":"Wegmuller S.","year":"2014","unstructured":"Wegmuller S.; Schmid S.; Recombinant peptide production in microbial cells. Curr Org Chem 2014,18(8),1005-1019","journal-title":"Curr Org Chem"},{"key":"ref=12","unstructured":"Lloyd, Ian Pharma r https:\/\/pharmaintelligence.informa.com\/resources\/product-content\/pharma-rnd-annual-review-[Accessed Sep 9, 2020]","journal-title":"Lloyd, Ian Pharma r"},{"key":"ref=13","unstructured":"Blaskovich, Mark Explainer: Peptides vs proteins - What\u2019s the difference? Available from: https:\/\/imb.uq.edu.au\/article\/2017\/11\/explainer-peptides-vs-proteins-whats-difference [Accessed Sep 9,2020]","journal-title":"Blaskovich, Mark Explainer: Peptides vs proteins - What\u2019s the difference? Available from:"},{"key":"ref=14","first-page":"978","author":"Gaiser R.A.","year":"2011","unstructured":"Gaiser R.A.; Rivas L.; Lopes P.; In: Science against Microbial Pathogens: Communicating Current Research and Technological Advances 2011,978-988","journal-title":"In: Science against Microbial Pathogens: Communicating Current Research and Technological Advances"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.pep.2011.08.001","volume":"80","author":"Li Y.","year":"2011","unstructured":"Li Y.; Recombinant production of antimicrobial peptides in Escherichia coli: A review. Protein Expr Purif 2011,80(2),260-267","journal-title":"Protein Expr Purif"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BA20060207","volume":"47","author":"Ingham A.B.","year":"2007","unstructured":"Ingham A.B.; Moore R.J.; Recombinant production of antimicrobial peptides in heterologous microbial systems. Biotechnol Appl Biochem 2007,47(1),1-9","journal-title":"Biotechnol Appl Biochem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.peptides.2012.09.020","volume":"38","author":"Parachin N.S.","year":"2012","unstructured":"Parachin N.S.; Mulder K.C.; Viana A.A.B.; Dias S.C.; Franco O.L.; Expression systems for heterologous production of antimicrobial peptides. Peptides 2012,38(2),446-456","journal-title":"Peptides"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10295-011-1082-9","volume":"39","author":"Huang C-J.","year":"2012","unstructured":"Huang C-J.; Lin H.; Yang X.; Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements. J Ind Microbiol Biotechnol 2012,39(3),383-399","journal-title":"J Ind Microbiol Biotechnol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1007\/s00253-014-5732-5","volume":"98","author":"Ahmad M.","year":"2014","unstructured":"Ahmad M.; Hirz M.; Pichler H.; Schwab H.; Protein expression in Pichia pastoris: Recent achievements and perspectives for heterologous protein production. Appl Microbiol Biotechnol 2014,98(12),5301-5317","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=20","author":"Merlin M.","unstructured":"Merlin M.; Gecchele E.; Capaldi S.; Pezzotti M.; Avesani L.; Comparative evaluation of recombinant protein production in different biofactories: The green perspective Biomed Res Int, 2014, 2014","journal-title":"Comparative evaluation of recombinant protein production in different biofactories: The green perspective Biomed Res Int, 2014, 2014"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/biot.201400438","volume":"10","author":"Felberbaum R.S.","year":"2015","unstructured":"Felberbaum R.S.; The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors. Biotechnol J 2015,10(5),702-714","journal-title":"Biotechnol J"},{"key":"ref=22","volume":"5","author":"Gharelo R.S.","year":"2016","unstructured":"Gharelo R.S.; Oliaei E.D.; Bandehagh A.; Khodadadi E.; Noparvar P.M.; Production of therapeutic proteins through plant tissue and cell culture. J Biosci Biotechnol 2016,5(1)","journal-title":"J Biosci Biotechnol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ymeth.2018.05.013","volume":"147","author":"McKenzie E.A.","year":"2018","unstructured":"McKenzie E.A.; Abbott W.M.; Expression of recombinant proteins in insect and mammalian cells. Methods 2018,147,40-49","journal-title":"Methods"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/B978-0-12-815407-6.00011-3","author":"Gupta S.K.","year":"2019","unstructured":"Gupta S.K.; Dangi A.K.; Smita M.; Dwivedi S.; Shukla P.; In: Applied microbiology and bioengineering 2019,203-227","journal-title":"In: Applied microbiology and bioengineering"},{"key":"ref=25","first-page":"450","volume":"5","author":"Khan K.","year":"2014","unstructured":"Khan K.; Gene expression systems and recombinant protein purification. Res J Pharm Biol Chem Sci 2014,5(6),450-463","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.biotechadv.2009.01.008","volume":"27","author":"Demain A.L.","year":"2009","unstructured":"Demain A.L.; Vaishnav P.; Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 2009,27(3),297-306","journal-title":"Biotechnol Adv"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00253-006-0465-8","volume":"72","author":"Terpe K.","year":"2006","unstructured":"Terpe K.; Overview of bacterial expression systems for heterologous protein production: From molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 2006,72(2),211","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/3527603670.ch4","author":"Freudl R.","year":"2005","unstructured":"Freudl R.; In: Production of recombinant proteins 2005,67-87","journal-title":"In: Production of recombinant proteins"},{"key":"ref=29","first-page":"1","author":"Gellissen G.","year":"2005","unstructured":"Gellissen G.; Strasser A.W.M.; Suckow M.; In: Prod Recomb proteins-Novel Microb 2005,1-5","journal-title":"In: Prod Recomb proteins-Novel Microb"},{"key":"ref=30","doi-asserted-by":"publisher","DOI":"10.1002\/3527603670.ch7","author":"Ilgen C.","year":"2005","unstructured":"Ilgen C.; Lin-Cereghino J.; Cregg J.M.; In: Production of recombinant proteins-novel microbial and eukaryotic expression systems 2005","journal-title":"In: Production of recombinant proteins-novel microbial and eukaryotic expression systems"},{"key":"ref=31","author":"Altenbuchner J.","year":"2004","unstructured":"Altenbuchner J.; Mattes R.; Prod Recomb proteins 2004","journal-title":"Prod Recomb proteins"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00253-010-3019-z","volume":"89","author":"Porro D.","year":"2011","unstructured":"Porro D.; Gasser B.; Fossati T.; Maurer M.; Branduardi P.; Sauer M.; Mattanovich D.; Production of recombinant proteins and metabolites in yeasts. Appl Microbiol Biotechnol 2011,89(4),939-948","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"953","DOI":"10.4014\/jmb.1412.12079","volume":"25","author":"Baeshen M.N.","year":"2015","unstructured":"Baeshen M.N.; Al-Hejin A.M.; Bora R.S.; Ahmed M.M.; Ramadan H.A.; Saini K.S.; Baeshen N.A.; Redwan E.M.; Production of biopharmaceuticals in E. coli: Current scenario and future perspectives. J Microbiol Biotechnol 2015,25(7),953-962","journal-title":"J Microbiol Biotechnol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3109\/07388551.2015.1084264","volume":"36","author":"Gupta S.K.","year":"2016","unstructured":"Gupta S.K.; Shukla P.; Advanced technologies for improved expression of recombinant proteins in bacteria: Perspectives and applications. Crit Rev Biotechnol 2016,36(6),1089-1098","journal-title":"Crit Rev Biotechnol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fbioe.2019.00420","author":"Tripathi N.K.","year":"2019","unstructured":"Tripathi N.K.; Shrivastava A.; Recent developments in bioprocessing of recombinant proteins: Expression hosts and process development. Front Bioeng Biotechnol 2019,7","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1007\/s00253-019-09925-6","volume":"103","author":"Liu M.","year":"2019","unstructured":"Liu M.; Wang B.; Wang F.; Yang Z.; Gao D.; Zhang C.; Ma L.; Yu X.; Soluble expression of single-chain variable fragment (scfv) in Escherichia coli using superfolder green fluorescent protein as fusion partner. Appl Microbiol Biotechnol 2019,103(15),6071-6079","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pep.2019.04.002","volume":"160","author":"Malekian R.","year":"2019","unstructured":"Malekian R.; Sima S.; Jahanian-Najafabadi A.; Moazen F.; Akbari V.; Improvement of soluble expression of gm-csf in the cytoplasm of Escherichia coli using chemical and molecular chaperones. Protein Expr Purif 2019,160,66-72","journal-title":"Protein Expr Purif"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-014-0183-3","volume":"14","author":"Mamat U.","year":"2015","unstructured":"Mamat U.; Wilke K.; Bramhill D.; Schromm A.B.; Lindner B.; Kohl T.A.; Corchero J.L.; Villaverde A.; Schaffer L.; Head S.R.; Souvignier C.; Meredith T.C.; Woodard R.W.; Detoxifying Escherichia coli for endotoxin-free production of recombinant proteins. Microb Cell Fact 2015,14(1),1-15","journal-title":"Microb Cell Fact"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1475-2859-8-17","volume":"8","author":"Ferrer-Miralles N.","year":"2009","unstructured":"Ferrer-Miralles N.; Domingo-Espin J.; Corchero J.L.; V&#xE1;zquez E.; Villaverde A.; Microbial factories for recombinant pharmaceuticals. Microb Cell Fact 2009,8(1),17","journal-title":"Microb Cell Fact"},{"key":"ref=40","author":"Wacker M.","unstructured":"Wacker M.; Linton D.; Hitchen P. G.; Nita-Lazar M.; Haslam S. M.; North S. J.; Panico M.; Morris H. R.; Dell A.; Wren B. W.; Aebi M.; N-linked glycosylation in Campylobacter jejuni and its functional transfer into E coli Science (80-), 2002, 298(5599), 1790-1793","journal-title":"N-linked glycosylation in Campylobacter jejuni and its functional transfer into E coli Science (80-), 2002, 298(5599), 1790-1793"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nchembio.921","volume":"8","author":"Valderrama-Rincon J.D.","year":"2012","unstructured":"Valderrama-Rincon J.D.; Fisher A.C.; Merritt J.H.; Fan Y-Y.; Reading C.A.; Chhiba K.; Heiss C.; Azadi P.; Aebi M.; DeLisa M.P.; An engineered eukaryotic protein glycosylation pathway in Escherichia coli. Nat Chem Biol 2012,8(5),434","journal-title":"Nat Chem Biol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fmicb.2014.00172","volume":"5","author":"Rosano G.L.","year":"2014","unstructured":"Rosano G.L.; Ceccarelli E.A.; Recombinant protein expression in Escherichia coli: Advances and challenges. Front Microbiol 2014,5,172","journal-title":"Front Microbiol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/pro.3668","volume":"28","author":"Rosano G.L.","year":"2019","unstructured":"Rosano G.L.; Morales E.S.; Ceccarelli E.A.; New tools for recombinant protein production in Escherichia coli: A 5-year update. Protein Sci 2019,28(8),1412-1422","journal-title":"Protein Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.biotechadv.2011.09.013","volume":"30","author":"Chen R.","year":"2012","unstructured":"Chen R.; Bacterial expression systems for recombinant protein production: E. coli and beyond. Biotechnol Adv 2012,30(5),1102-1107","journal-title":"Biotechnol Adv"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5681\/apb","volume":"3","author":"Hayat Khan K.","year":"2013","unstructured":"Hayat Khan K.; Gene expression in mammalian cells and its applications. Adv Pharm Bull 2013,3(2),257-263","journal-title":"Adv Pharm Bull"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4161\/bioe.22856","volume":"4","author":"Nielsen J.","year":"2013","unstructured":"Nielsen J.; Production of biopharmaceutical proteins by yeast: Advances through metabolic engineering. Bioengineered 2013,4(4),207-211","journal-title":"Bioengineered"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/bit.25870","volume":"113","author":"Fletcher E.","year":"2016","unstructured":"Fletcher E.; Krivoruchko A.; Nielsen J.; Industrial systems biology and its impact on synthetic biology of yeast cell factories. Biotechnol Bioeng 2016,113(6),1164-1170","journal-title":"Biotechnol Bioeng"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/microorganisms6020038","volume":"6","author":"Vieira Gomes A.M.","year":"2018","unstructured":"Vieira Gomes A.M.; Souza Carmo T.; Silva Carvalho L.; Mendon&#xE7;a Bahia F.; Parachin N.S.; Comparison of yeasts as hosts for recombinant protein production. Microorganisms 2018,6(2),38","journal-title":"Microorganisms"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s12033-019-00164-8","volume":"61","author":"Baghban R.","year":"2019","unstructured":"Baghban R.; Farajnia S.; Rajabibazl M.; Ghasemi Y.; Mafi A.; Hoseinpoor R.; Rahbarnia L.; Aria M.; Yeast expression systems: Overview and recent advances. Mol Biotechnol 2019,61(5),365-384","journal-title":"Mol Biotechnol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/1751-7915.13342","volume":"12","author":"Huertas M.J.","year":"2019","unstructured":"Huertas M.J.; Mich&#xE1;n C.; Paving the way for the production of secretory proteins by yeast cell factories. Microb Biotechnol 2019,12(6),1095","journal-title":"Microb Biotechnol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"E11025","DOI":"10.1073\/pnas.1809921115","volume":"115","author":"Huang M.","year":"2018","unstructured":"Huang M.; Wang G.; Qin J.; Petranovic D.; Nielsen J.; Engineering the protein secretory pathway of Saccharomyces cerevisiae enables improved protein production. Proc Natl Acad Sci USA 2018,115(47),E11025-E11032","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3389\/fphar.2017.00419","volume":"8","author":"Gupta S.K.","year":"2017","unstructured":"Gupta S.K.; Shukla P.; Sophisticated cloning, fermentation, and purification technologies for an enhanced therapeutic protein production: A review. Front Pharmacol 2017,8,419","journal-title":"Front Pharmacol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.biotechadv.2015.05.008","volume":"33","author":"Looser V.","year":"2015","unstructured":"Looser V.; Bruhlmann B.; Bumbak F.; Stenger C.; Costa M.; Camattari A.; Fotiadis D.; Kovar K.; Cultivation strategies to enhance productivity of Pichia pastoris: A review. Biotechnol Adv 2015,33(6),1177-1193","journal-title":"Biotechnol Adv"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/cbic.201700460","volume":"19","author":"Juturu V.","year":"2018","unstructured":"Juturu V.; Wu J.C.; Heterologous protein expression in Pichia pastoris: Latest research progress and applications. ChemBioChem 2018,19(1),7-21","journal-title":"ChemBioChem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.biotechadv.2017.11.002","volume":"36","author":"Yang Z.","year":"2018","unstructured":"Yang Z.; Zhang Z.; Engineering strategies for enhanced production of protein and bio-products in Pichia pastoris: A review. Biotechnol Adv 2018,36(1),182-195","journal-title":"Biotechnol Adv"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.biotechadv.2019.03.012","volume":"37","author":"Werten M.W.T.","year":"2019","unstructured":"Werten M.W.T.; Eggink G.; Stuart M.A.C.; de Wolf F.A.; Production of protein-based polymers in Pichia pastoris. Biotechnol Adv 2019,37(5),642-666","journal-title":"Biotechnol Adv"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/bit.20318","volume":"89","author":"Sinha J.","year":"2005","unstructured":"Sinha J.; Plantz B.A.; Inan M.; Meagher M.M.; Causes of proteolytic degradation of secreted recombinant proteins produced in methylotrophic yeast Pichia pastoris: Case study with recombinant ovine interferon-&#x3C4;. Biotechnol Bioeng 2005,89(1),102-112","journal-title":"Biotechnol Bioeng"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/BF03175354","volume":"57","author":"Zhang Y.","year":"2007","unstructured":"Zhang Y.; Liu R.; Wu X.; The proteolytic systems and heterologous proteins degradation in the methylotrophic yeast Pichia pastoris. Ann Microbiol 2007,57(4),553","journal-title":"Ann Microbiol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1099\/mic.0.000599","volume":"164","author":"Dyo Y.M.","year":"2018","unstructured":"Dyo Y.M.; Purton S.; The algal chloroplast as a synthetic biology platform for production of therapeutic proteins. Microbiology 2018,164,113-121","journal-title":"Microbiology"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12934-017-0734-5","volume":"16","author":"Havlik D.","year":"2017","unstructured":"Havlik D.; Brandt U.; Bohle K.; Flei&#xDF;ner A.; Establishment of Neurospora crassa as a host for heterologous protein production using a human antibody fragment as a model product. Microb Cell Fact 2017,16(1),128","journal-title":"Microb Cell Fact"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00284-017-1348-1","volume":"75","author":"Maga&#xF1;a-Ortiz D.","year":"2018","unstructured":"Maga&#xF1;a-Ortiz D.; Fern&#xE1;ndez F.; Loske A.M.; G&#xF3;mez-Lim M.A.; Extracellular expression in Aspergillus niger of an antibody fused to leishmania sp. antigens. Curr Microbiol 2018,75(1),40-48","journal-title":"Curr Microbiol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/btpr.1842","volume":"30","author":"Contreras-G&#xF3;mez A.","year":"2014","unstructured":"Contreras-G&#xF3;mez A.; S&#xE1;nchez-Mir&#xF3;n A.; Garcia-Camacho F.; Molina-Grima E.; Chisti Y.; Protein production using the baculovirus-insect cell expression system. Biotechnol Prog 2014,30(1),1-18","journal-title":"Biotechnol Prog"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-3-319-27216-0_12","author":"Kost T.A.","year":"2016","unstructured":"Kost T.A.; Kemp C.W.; In: Advanced Technologies for Protein Complex Production and Characterization 2016,187-197","journal-title":"In: Advanced Technologies for Protein Complex Production and Characterization"},{"key":"ref=64","doi-asserted-by":"publisher","DOI":"10.3791\/52459","author":"Gecchele E.","year":"2015","unstructured":"Gecchele E.; Merlin M.; Brozzetti A.; Falorni A.; Pezzotti M.; Avesani L.; A comparative analysis of recombinant protein expression in different biofactories: Bacteria, insect cells and plant systems. J Vis Exp 2015(97)","journal-title":"J Vis Exp"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1099\/vir.0.067108-0","volume":"96","author":"Van Oers M.M.","year":"2015","unstructured":"Van Oers M.M.; Pijlman G.P.; Vlak J.M.; Thirty years of baculovirus-insect cell protein expression: From dark horse to mainstream technology. J Gen Virol 2015,96(1),6-23","journal-title":"J Gen Virol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"10061","DOI":"10.1021\/acs.iecr.8b00985","volume":"57","author":"Yee C.M.","year":"2018","unstructured":"Yee C.M.; Zak A.J.; Hill B.D.; Wen F.; The coming age of insect cells for manufacturing and development of protein therapeutics. Ind Eng Chem Res 2018,57(31),10061-10070","journal-title":"Ind Eng Chem Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bej.2018.12.011","volume":"143","author":"Ghasemi A.","year":"2019","unstructured":"Ghasemi A.; Bozorg A.; Rahmati F.; Mirhassani R.; Hosseininasab S.; Comprehensive study on wave bioreactor system to scale up the cultivation of and recombinant protein expression in baculovirus-infected insect cells. Biochem Eng J 2019,143,121-130","journal-title":"Biochem Eng J"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12033-017-0041-8","volume":"60","author":"Le L.T.M.","year":"2018","unstructured":"Le L.T.M.; Nyengaard J.R.; Golas M.M.; Sander B.; Vectors for expression of signal peptide-dependent proteins in baculovirus\/insect cell systems and their application to expression and purification of the high-affinity immunoglobulin gamma fc receptor i in complex with its gamma chain. Mol Biotechnol 2018,60(1),31-40","journal-title":"Mol Biotechnol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3109\/07388551.2015.1084266","volume":"36","author":"Dumont J.","year":"2016","unstructured":"Dumont J.; Euwart D.; Mei B.; Estes S.; Kshirsagar R.; Human cell lines for biopharmaceutical manufacturing: History, status, and future perspectives. Crit Rev Biotechnol 2016,36(6),1110-1122","journal-title":"Crit Rev Biotechnol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.febslet.2013.11.035","volume":"588","author":"Bandaranayake A.D.","year":"2014","unstructured":"Bandaranayake A.D.; Almo S.C.; Recent advances in mammalian protein production. FEBS Lett 2014,588(2),253-260","journal-title":"FEBS Lett"},{"key":"ref=71","doi-asserted-by":"publisher","DOI":"10.1002\/cpps.77","volume":"95","author":"Hunter M.","year":"2019","unstructured":"Hunter M.; Yuan P.; Vavilala D.; Fox M.; Optimization of protein expression in mammalian cells. Curr Protoc Protein Sci 2019,95(1)","journal-title":"Curr Protoc Protein Sci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-1-4939-6430-7_10","author":"Nishida T.","year":"2017","unstructured":"Nishida T.; Kubota S.; Takigawa M.; In: CCN proteins 2017,95-105","journal-title":"In: CCN proteins"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jbiotec.2017.04.028","volume":"251","author":"Lalonde M-E.","year":"2017","unstructured":"Lalonde M-E.; Durocher Y.; Therapeutic glycoprotein production in mammalian cells. J Biotechnol 2017,251,128-140","journal-title":"J Biotechnol"},{"key":"ref=74","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9746720","volume":"2017","author":"Wang X.","year":"2017","unstructured":"Wang X.; Yu H.; Xing R.; Li P.; Characterization, preparation, and purification of marine bioactive peptides. BioMed Res Int 2017,2017(1)","journal-title":"BioMed Res Int"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/10_2017_57]","volume":"175","author":"Heffner K.M.","year":"2021","unstructured":"Heffner K.M.; Wang Q.; Hizal D.B.; Can &#xD6;.; Betenbaugh M.J.; Glycoengineering of mammalian expression systems on a cellular level. Adv Biochem Eng Biotechnol 2021,175,37-69","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.32607\/20758251-2013-5-1-33-46","volume":"5","author":"Maksimenko O.G.","year":"2013","unstructured":"Maksimenko O.G.; Deykin A.V.; Georgiev P.G.; Use of transgenic animals in biotechnology: Prospects and problems. Acta Naturae 2013,5(1),33-46","journal-title":"Acta Naturae"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cimid.2007.11.005","volume":"32","author":"Houdebine L-M.","year":"2009","unstructured":"Houdebine L-M.; Production of pharmaceutical proteins by transgenic animals. Comp Immunol Microbiol Infect Dis 2009,32(2),107-121","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1590\/S1516-89132011000500010","volume":"54","author":"Moura R.R.","year":"2011","unstructured":"Moura R.R.; Melo L.M.; Freitas V.J.; de F. Production of recombinant proteins in milk of transgenic and non-transgenic goats. Braz Arch Biol Technol 2011,54(5),927-938","journal-title":"Braz Arch Biol Technol"},{"key":"ref=79","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4216060","volume":"2019","author":"Owczarek B.","year":"2019","unstructured":"Owczarek B.; Gerszberg A.; Hnatuszko-Konka K.; A brief reminder of systems of production and chromatography-based recovery of recombinant protein biopharmaceuticals. BioMed Res Int 2019,2019","journal-title":"BioMed Res Int"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3390\/ph6060728","volume":"6","author":"Wang G.","year":"2013","unstructured":"Wang G.; Database-guided discovery of potent peptides to combat HIV-1 or superbugs. Pharmaceuticals 2013,6(6),728-758","journal-title":"Pharmaceuticals"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11248-016-9933-9","volume":"25","author":"Bertolini L.R.","year":"2016","unstructured":"Bertolini L.R.; Meade H.; Lazzarotto C.R.; Martins L.T.; Tavares K.C.; Bertolini M.; Murray J.D.; The transgenic animal platform for biopharmaceutical production. Transgenic Res 2016,25(3),329-343","journal-title":"Transgenic Res"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/21655979.2016.1171429","volume":"7","author":"Monzani P.S.","year":"2016","unstructured":"Monzani P.S.; Adona P.R.; Ohashi O.M.; Meirelles F.V.; Wheeler M.B.; Transgenic bovine as bioreactors: Challenges and perspectives. Bioengineered 2016,7(3),123-131","journal-title":"Bioengineered"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/BF00034942","volume":"6","author":"Barta A.","year":"1986","unstructured":"Barta A.; Sommergruber K.; Thompson D.; Hartmuth K.; Matzke M.A.; Matzke A.J.M.; The expression of a nopaline synthase-human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue. Plant Mol Biol 1986,6(5),347-357","journal-title":"Plant Mol Biol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s10529-014-1699-7","volume":"37","author":"Fahad S.","year":"2015","unstructured":"Fahad S.; Khan F.A.; Pandupuspitasari N.S.; Ahmed M.M.; Liao Y.C.; Waheed M.T.; Sameeullah M.; Hussain S.; Saud S.; Hassan S.; Jan A.; Jan M.T.; Wu C.; Chun M.X.; Huang J.; Recent developments in therapeutic protein expression technologies in plants. Biotechnol Lett 2015,37(2),265-279","journal-title":"Biotechnol Lett"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"28549","DOI":"10.3390\/ijms161226122","volume":"16","author":"Yao J.","year":"2015","unstructured":"Yao J.; Weng Y.; Dickey A.; Wang K.Y.; Plants as factories for human pharmaceuticals: Applications and challenges. Int J Mol Sci 2015,16(12),28549-28565","journal-title":"Int J Mol Sci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pep.2015.12.018","volume":"120","author":"\u0141ojewska E.","year":"2016","unstructured":"\u0141ojewska E.; Kowalczyk T.; Olejniczak S.; Sakowicz T.; Extraction and purification methods in downstream processing of plant-based recombinant proteins. Protein Expr Purif 2016,120,110-117","journal-title":"Protein Expr Purif"},{"key":"ref=87","author":"Lomonossoff G. P.","unstructured":"Lomonossoff G. P.; D'Aoust M.-A.; Plant-produced biopharmaceuticals: A case of technical developments driving clinical deploymentScience (80-), 2016, 353(6305), 1237-1240","journal-title":"Plant-produced biopharmaceuticals: A case of technical developments driving clinical deploymentScience (80-), 2016, 353(6305), 1237-1240"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s12374-016-0482-9","volume":"59","author":"Park K.Y.","year":"2016","unstructured":"Park K.Y.; Wi S.J.; Potential of plants to produce recombinant protein products. J Plant Biol 2016,59(6),559-568","journal-title":"J Plant Biol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.biotechadv.2017.03.011","volume":"35","author":"Buyel J.F.","year":"2017","unstructured":"Buyel J.F.; Twyman R.M.; Fischer R.; Very-large-scale production of antibodies in plants: The biologization of manufacturing. Biotechnol Adv 2017,35(4),458-465","journal-title":"Biotechnol Adv"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11738-016-2315-3","volume":"39","author":"Dirisala V.R.","year":"2017","unstructured":"Dirisala V.R.; Nair R.R.; Srirama K.; Reddy P.N.; Rao K.R.S.S.; Kumar N.S.S.; Parvatam G.; Recombinant pharmaceutical protein production in plants: Unraveling the therapeutic potential of molecular pharming. Acta Physiol Plant 2017,39(1),18","journal-title":"Acta Physiol Plant"},{"key":"ref=91","first-page":"509","author":"Xu J.","year":"2018","unstructured":"Xu J.; Towler M.; Weathers P.J.; Platforms for plant-based protein production Bioprocess Plant Vitr 2018,509","journal-title":"Platforms for plant-based protein production Bioprocess Plant Vitr"},{"key":"ref=92","author":"Rech Filho E.L.","unstructured":"Rech Filho E.L.; Vianna G.R.; Murad A.M.; Cunha N.; Lacorte C.C.; De Araujo A.C.G.; Brigido M.; Michael W.; Fontes A.; Barry O.; Andrew S.; Otavia C.; Recombinant proteins in plantsBMC Proc, 2014, vol 8, suppl, P01","journal-title":"Recombinant proteins in plantsBMC Proc, 2014, vol 8, suppl, P01"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/10_2018_76","volume":"Vol. 175","author":"Fischer R.","year":"2018","unstructured":"Fischer R.; Holland T.; Sack M.; Schillberg S.; Stoger E.; Twyman R.M.; Buyel J.F.; Advances in Glycobiotechnology 2018,Vol. 175,137-166","journal-title":"Advances in Glycobiotechnology"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.coviro.2017.07.019","volume":"26","author":"Loh H-S.","year":"2017","unstructured":"Loh H-S.; Green B.J.; Yusibov V.; Using transgenic plants and modified plant viruses for the development of treatments for human diseases. Curr Opin Virol 2017,26,81-89","journal-title":"Curr Opin Virol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s00018-007-6475-6","volume":"64","author":"Mookherjee N.","year":"2007","unstructured":"Mookherjee N.; Hancock R.E.W.; Cationic host defence peptides: Innate immune regulatory peptides as a novel approach for treating infections. Cell Mol Life Sci 2007,64(7\u20138),922","journal-title":"Cell Mol Life Sci"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ijantimicag.2004.09.005","volume":"24","author":"Reddy K.V.R.","year":"2004","unstructured":"Reddy K.V.R.; Yedery R.D.; Aranha C.; Antimicrobial peptides: Premises and promises. Int J Antimicrob Agents 2004,24(6),536-547","journal-title":"Int J Antimicrob Agents"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1038\/nbt1267","volume":"24","author":"Hancock R.E.W.","year":"2006","unstructured":"Hancock R.E.W.; Sahl H-G.; Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 2006,24(12),1551","journal-title":"Nat Biotechnol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.dci.2009.10.006","volume":"34","author":"Li C.","year":"2010","unstructured":"Li C.; Blencke H.M.; Smith L.C.; Karp M.T.; Stensv&#xE5;g K.; Two recombinant peptides, spstrongylocins 1 and 2, from Strongylocentrotus purpuratus, show antimicrobial activity against gram-positive and gram-negative bacteria. Dev Comp Immunol 2010,34(3),286-292","journal-title":"Dev Comp Immunol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.pep.2017.06.007","volume":"136","author":"Guill&#xE9;n-Chable F.","year":"2017","unstructured":"Guill&#xE9;n-Chable F.; Arenas-Sosa I.; Islas-Flores I.; Corzo G.; Martinez-Liu C.; Estrada G.; Antibacterial activity and phospholipid recognition of the recombinant defensin j1-1 from capsicum genus. Protein Expr Purif 2017,136,45-51","journal-title":"Protein Expr Purif"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.dci.2015.02.009","volume":"51","author":"Zhang L.","year":"2015","unstructured":"Zhang L.; Yang D.; Wang Q.; Yuan Z.; Wu H.; Pei D.; Cong M.; Li F.; Ji C.; Zhao J.; A defensin from clam Venerupis philippinarum: Molecular characterization, localization, antibacterial activity, and mechanism of action. Dev Comp Immunol 2015,51(1),29-38","journal-title":"Dev Comp Immunol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.pep.2018.03.001","volume":"2018","author":"Meng D.M.","year":"2017","unstructured":"Meng D.M.; Lv Y.J.; Zhao J.F.; Liu Q.Y.; Shi L.Y.; Wang J.P.; Yang Y.H.; Fan Z.C.; Efficient production of a recombinant Venerupis philippinarum defensin (vpdef) in Pichia pastoris and characterization of its antibacterial activity and stability. Protein Expr Purif 2017,2018(147),78-84","journal-title":"Protein Expr Purif"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/btpr.528","volume":"27","author":"Tseng J-M.","year":"2011","unstructured":"Tseng J-M.; Huang J-R.; Huang H-C.; Tzen J.T.C.; Chou W-M.; Peng C-C.; Facilitative production of an antimicrobial peptide royalisin and its antibody via an artificial oil-body system. Biotechnol Prog 2011,27(1),153-161","journal-title":"Biotechnol Prog"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.peptides.2015.03.001","volume":"68","author":"B&#xED;likova K.","year":"2015","unstructured":"B&#xED;likova K.; Huang S.C.; Lin I.P.; \u0160imuth J.; Peng C.C.; Structure and antimicrobial activity relationship of royalisin, an antimicrobial peptide from royal jelly of apis mellifera. Peptides 2015,68,190-196","journal-title":"Peptides"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pep.2016.02.002","volume":"122","author":"Kuddus M.R.","year":"2016","unstructured":"Kuddus M.R.; Rumi F.; Tsutsumi M.; Takahashi R.; Yamano M.; Kamiya M.; Kikukawa T.; Demura M.; Aizawa T.; Expression, purification and characterization of the recombinant cysteine-rich antimicrobial peptide snakin-1 in Pichia pastoris. Protein Expr Purif 2016,122,15-22","journal-title":"Protein Expr Purif"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1111\/j.1742-4658.2005.04852.x","volume":"272","author":"Scocchi M.","year":"2005","unstructured":"Scocchi M.; Zelezetsky I.; Benincasa M.; Gennaro R.; Mazzoli A.; Tossi A.; Structural aspects and biological properties of the cathelicidin pmap-36. FEBS J 2005,272(17),4398-4406","journal-title":"FEBS J"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0014-5793(94)80214-9","volume":"337","author":"Storici P.","year":"1994","unstructured":"Storici P.; Scocchi M.; Tossi A.; Gennaro R.; Zanetti M.; Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid CDNA. FEBS Lett 1994,337(3),303-307","journal-title":"FEBS Lett"},{"key":"ref=107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086364","volume":"9","author":"Lv Y.","year":"2014","unstructured":"Lv Y.; Wang J.; Gao H.; Wang Z.; Dong N.; Ma Q.; Shan A.; Antimicrobial properties and membrane-active mechanism of a potential $&#x3B1;$-helical antimicrobial derived from cathelicidin pmap-36. PLoS One 2014,9(1)","journal-title":"PLoS One"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"27258","DOI":"10.1038\/srep27258","volume":"6","author":"Lyu Y.","year":"2016","unstructured":"Lyu Y.; Yang Y.; Lyu X.; Dong N.; Shan A.; Antimicrobial activity, improved cell selectivity and mode of action of short pmap-36-derived peptides against bacteria and candida. Sci Rep 2016,6,27258","journal-title":"Sci Rep"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"262","DOI":"10.14348\/molcells.2019.2365","volume":"42","author":"Rao Z.","year":"2019","unstructured":"Rao Z.; Kim S.Y.; Akanda M.R.; Lee S.J.; Jung I.D.; Park B.Y.; Kamala-Kannan S.; Hur J.; Park J.H.; Enhanced expression and functional characterization of the recombinant putative lysozyme-pmap36 fusion protein. Mol Cells 2019,42(3),262-269","journal-title":"Mol Cells"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1128\/AAC.50.4.1251-1256.2006","volume":"50","author":"Saugar J.M.","year":"2006","unstructured":"Saugar J.M.; Rodriguez-Hern&#xE1;ndez M.J.; Beatriz G.; Pach&#xF3;n-Iba&#xF1;ez M.E.; Fern&#xE1;ndez-Reyes M.; Andreu D.; Pach&#xF3;n J.; Rivas L.; Activity of cecropin a-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: Molecular basis for the differential mechanisms of action. Antimicrob Agents Chemother 2006,50(4),1251-1256","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3390\/ijms18020339","volume":"18","author":"Tan T.","year":"2017","unstructured":"Tan T.; Wu D.; Li W.; Zheng X.; Li W.; Shan A.; High specific selectivity and membrane-active mechanism of synthetic cationic hybrid antimicrobial peptides based on the peptide fv7. Int J Mol Sci 2017,18(2),339","journal-title":"Int J Mol Sci"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.bpj.2009.09.060","volume":"98","author":"Thennarasu S.","year":"2010","unstructured":"Thennarasu S.; Tan A.; Penumatchu R.; Shelburne C.E.; Heyl D.L.; Ramamoorthy A.; Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide ll37. Biophys J 2010,98(2),248-257","journal-title":"Biophys J"},{"key":"ref=113","first-page":"915","author":"Ramos R.","year":"2011","unstructured":"Ramos R.; Domingues L.; Gama M.; LL37, a human antimicrobial peptide with immunomodulatory properties. Sci. against. Microb Pathog 2011,915-925","journal-title":"Microb Pathog"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/ph7050545","volume":"7","author":"Wang G.","year":"2014","unstructured":"Wang G.; Human antimicrobial peptides and proteins. Pharmaceuticals 2014,7(5),545-594","journal-title":"Pharmaceuticals"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.peptides.2003.08.003","volume":"24","author":"Giacometti A.","year":"2003","unstructured":"Giacometti A.; Cirioni O.; Kamysz W.; D\u2019Amato G.; Silvestri C.; Del Prete M.S.; \u0141ukasiak J.; Scalise G.; Comparative activities of cecropin a, melittin, and cecropin a- melittin peptide ca (1--7) m (2--9) nh2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. Peptides 2003,24(9),1315-1318","journal-title":"Peptides"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10989-014-9430-z","volume":"21","author":"Bacalum M.","year":"2015","unstructured":"Bacalum M.; Radu M.; Cationic antimicrobial peptides cytotoxicity on mammalian cells: An analysis using therapeutic index integrative concept. Int J Pept Res Ther 2015,21(1),47-55","journal-title":"Int J Pept Res Ther"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/ijms17070983","volume":"17","author":"Wei X-B.","year":"2016","unstructured":"Wei X-B.; Wu R-J.; Si D-Y.; Liao X-D.; Zhang L-L.; Zhang R-J.; Novel hybrid peptide cecropin a (1-8)-ll37 (17-30) with potential antibacterial activity. Int J Mol Sci 2016,17(7),983","journal-title":"Int J Mol Sci"},{"key":"ref=118","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23061491","volume":"23","author":"Wei X.","year":"2018","unstructured":"Wei X.; Wu R.; Zhang L.; Ahmad B.; Si D.; Zhang R.; Expression, purification, and characterization of a novel hybrid peptide with potent antibacterial activity. Molecules 2018,23(6)","journal-title":"Molecules"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.dci.2016.03.006","volume":"61","author":"Al Souhail Q.","year":"2016","unstructured":"Al Souhail Q.; Hiromasa Y.; Rahnamaeian M.; Giraldo M.C.; Takahashi D.; Valent B.; Vilcinskas A.; Kanost M.R.; Characterization and regulation of expression of an antifungal peptide from hemolymph of an insect, Manduca sexta. Dev Comp Immunol 2016,61,258-268","journal-title":"Dev Comp Immunol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.biochi.2012.09.019","volume":"95","author":"Yamane E.S.","year":"2013","unstructured":"Yamane E.S.; Bizerra F.C.; Oliveira E.B.; Moreira J.T.; Rajabi M.; Nunes G.L.C.; De Souza A.O.; Da Silva I.D.C.G.; Yamane T.; Karpel R.L.; Silva P.I.; Hayashi M.A.F.; Unraveling the antifungal activity of a south american rattlesnake toxin crotamine. Biochimie 2013,95(2),231-240","journal-title":"Biochimie"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.011","volume":"68","author":"Zhang J.","year":"2015","unstructured":"Zhang J.; Movahedi A.; Wang X.; Wu X.; Yin T.; Zhuge Q.; Molecular structure, chemical synthesis, and antibacterial activity of abp-dhc-cecropin a from drury (Hyphantria cunea). Peptides 2015,68,197-204","journal-title":"Peptides"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jbiotec.2015.02.018","volume":"199","author":"Zhang J.","year":"2015","unstructured":"Zhang J.; Movahedi A.; Xu J.; Wang M.; Wu X.; Xu C.; Yin T.; Zhuge Q.; In vitro production and antifungal activity of peptide abp-dhc-cecropin A. J Biotechnol 2015,199,47-54","journal-title":"J Biotechnol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.plaphy.2013.05.022","volume":"70","author":"Astafieva A.A.","year":"2013","unstructured":"Astafieva A.A.; Rogozhin E.A.; Andreev Y.A.; Odintsova T.I.; Kozlov S.A.; Grishin E.V.; Egorov T.A.; A novel cysteine-rich antifungal peptide toamp4 from Taraxacum officinale wigg. flowers. Plant Physiol Biochem 2013,70,93-99","journal-title":"Plant Physiol Biochem"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2229-8-75","volume":"8","author":"De Beer A.","year":"2008","unstructured":"De Beer A.; Vivier M.A.; Vv-AMP1, a ripening induced peptide from Vitis vinifera shows strong antifungal activity. BMC Plant Biol 2008,8,1-16","journal-title":"BMC Plant Biol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2229-12-180","author":"Picart P.","year":"2012","unstructured":"Picart P.; Pirttil&#xE4; A.M.; Raventos D.; Kristensen H.H.; Sahl H.G.; Identification of defensin-encoding genes of Picea glauca: Characterization of pgd5, a conserved spruce defensin with strong antifungal activity. BMC Plant Biol 2012,12","journal-title":"BMC Plant Biol"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1271\/bbb.58.1476","volume":"58","author":"Yamano Y.","year":"1994","unstructured":"Yamano Y.; Matsumoto M.; Inoue K.; Kawabata T.; Cloning of cdnas for cecropins A and B, and expression of the genes in the silkworm, Bombyx mori. Biosci Biotechnol Biochem 1994,58(8),1476-1478","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1271\/bbb.62.237","volume":"62","author":"Yamano Y.","year":"1998","unstructured":"Yamano Y.; Matsumoto M.; Sasahara K.; Sakamoto E.; Morishima I.; Structure of genes for cecropin a and an inducible nuclear protein that binds to the promoter region of the genes from the silkworm, Bombyx mori. Biosci Biotechnol Biochem 1998,62(2),237-241","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0305-0491(99)00015-2","volume":"122","author":"Yang J.","year":"1999","unstructured":"Yang J.; Furukawa S.; Sagisaka A.; Ishibashi J.; Taniai K.; Shono T.; Yamakawa M.; CDNA cloning and gene expression of cecropin D, an antibacterial protein in the silkworm, Bombyx mori. Comp Biochem Physiol B Biochem Mol Biol 1999,122(4),409-414","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1094\/MPMI.1998.11.3.218","volume":"11","author":"Cavallarin L.","year":"1998","unstructured":"Cavallarin L.; Andreu D.; San Segundo B.; Cecropin a derived peptides are potent inhibitors of fungal plant pathogens. Mol Plant Microbe Interact 1998,11(3),218-227","journal-title":"Mol Plant Microbe Interact"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pep.2013.02.013","volume":"90","author":"Xia L.","year":"2013","unstructured":"Xia L.; Liu Z.; Ma J.; Sun S.; Yang J.; Zhang F.; Expression, purification and characterization of cecropin antibacterial peptide from Bombyx mori in Saccharomyces cerevisiae. Protein Expr Purif 2013,90(1),47-54","journal-title":"Protein Expr Purif"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/arch.21193","volume":"88","author":"Lee E.","year":"2015","unstructured":"Lee E.; Shin A.; Kim Y.; Anti-inflammatory activities of cecropin A and its mechanism of action. Arch Insect Biochem Physiol 2015,88(1),31-44","journal-title":"Arch Insect Biochem Physiol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.gene.2016.02.045","volume":"583","author":"Lu D.","year":"2016","unstructured":"Lu D.; Geng T.; Hou C.; Huang Y.; Qin G.; Guo X.; Bombyx mori cecropin a has a high antifungal activity to entomopathogenic fungus Beauveria bassiana. Gene 2016,583(1),29-35","journal-title":"Gene"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biochi.2013.11.005","volume":"99","author":"Ryazantsev D.Y.","year":"2014","unstructured":"Ryazantsev D.Y.; Rogozhin E.A.; Dimitrieva T.V.; Drobyazina P.E.; Khadeeva N.V.; Egorov T.A.; Grishin E.V.; Zavriev S.K.; A novel hairpin-like antimicrobial peptide from barnyard grass (Echinochloa crusgalli l.) seeds: Structure-functional and molecular-genetics characterization. Biochimie 2014,99(1),63-70","journal-title":"Biochimie"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00253-008-1648-2","volume":"80","author":"Vijayan S.","year":"2008","unstructured":"Vijayan S.; Guruprasad L.; Kirti P.B.; Prokaryotic expression of a constitutively expressed Tephrosia villosa defensin and its potent antifungal activity. Appl Microbiol Biotechnol 2008,80(6),1023-1032","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/psc.1147","volume":"15","author":"Yokoyama S.","year":"2009","unstructured":"Yokoyama S.; Iida Y.; Kawasaki Y.; Minami Y.; Watanabe K.; Yagi F.; The chitin-binding capability of cy-amp1 from cycad is essential to antifungal activity. J Pept Sci 2009,15(7),492-497","journal-title":"J Pept Sci"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1134\/S1068162008030096","volume":"34","author":"Baskova I.P.","year":"2008","unstructured":"Baskova I.P.; Zavalova L.L.; Polyfunctionality of lysozyme destabilase from the medicinal leech. Russ J Bioorganic Chem 2008,34(3),304-309","journal-title":"Russ J Bioorganic Chem"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11705-012-1277-2","volume":"6","author":"Yudina T.G.","year":"2012","unstructured":"Yudina T.G.; Guo D.; Piskunkova N.F.; Pavlova I.B.; Zavalova L.L.; Baskova I.P.; Antifungal and antibacterial functions of medicinal leech recombinant destabilase-lysozyme and its heated-up derivative. Front Chem Sci Eng 2012,6(2),203-209","journal-title":"Front Chem Sci Eng"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1258\/ebm.2011.011i01","volume":"236","author":"Endy T.P.","year":"2011","unstructured":"Endy T.P.; Rochford R.; Yuen K-Y.; Lei H-Y.; Emerging infectious diseases as a global health threat. Exp Biol Med (Maywood) 2011,236(8),897-898","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=139","first-page":"1","volume":"99","author":"&#xD6;rtqvist &#xC5;and Blennow M.","year":"2010","unstructured":"&#xD6;rtqvist &#xC5;and Blennow M.; Carlsson R-M.; Hanson L.; &#xC5;and Lindberg A.; Lindqvist L.; Magnusson M.; Nilsson L.; Norlund A.; Nyr&#xE9;n O.; Vaccination of children - A systematic review. Acta Paediatr 2010,99,1-192","journal-title":"Acta Paediatr"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.antiviral.2009.10.007","volume":"85","author":"Est&#xE9; J.A.","year":"2010","unstructured":"Est&#xE9; J.A.; Cihlar T.; Current status and challenges of antiretroviral research and therapy. Antiviral Res 2010,85(1),25-33","journal-title":"Antiviral Res"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gks450","volume":"40","author":"Thakur N.","year":"2012","unstructured":"Thakur N.; Qureshi A.; Kumar M.; AVPpred: Collection and prediction of highly effective antiviral peptides. Nucleic Acids Res 2012,40(W1),W199-W204","journal-title":"Nucleic Acids Res"},{"key":"ref=142","author":"Wyatt R.","unstructured":"Wyatt R.; Sodroski J.; The hiv-1 envelope glycoproteins: Fusogens, antigens, and immunogens Science (80), 1998, 280(5371), 1884-1888","journal-title":"The hiv-1 envelope glycoproteins: Fusogens, antigens, and immunogens Science (80), 1998, 280(5371), 1884-1888"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1099\/0022-1317-83-8-1809","volume":"83","author":"Clapham P.R.","year":"2002","unstructured":"Clapham P.R.; McKnight &#xC1;.; Cell surface receptors, virus entry and tropism of primate lentiviruses. J Gen Virol 2002,83(8),1809-1829","journal-title":"J Gen Virol"},{"key":"ref=144","author":"Delcroix-gen&#xEA;te D.","unstructured":"Delcroix-gen&#xEA;te D.; Quan P.; Roger M.; Delcroix-gen&#xEA;te D.; Quan P.; Roger M.; Hazan U.; Nisole S.; Proteins 2006 To Cite This Version : HAL Id : Inserm-00081431 Retrovirology","journal-title":"Proteins 2006 To Cite This Version : HAL Id : Inserm-00081431 Retrovirology"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.dci.2005.04.003","volume":"30","author":"Gueguen Y.","year":"2006","unstructured":"Gueguen Y.; Garnier J.; Robert L.; Lefranc M-P.; Mougenot I.; De Lorgeril J.; Janech M.; Gross P.S.; Warr G.W.; Cuthbertson B.; PenBase, the shrimp antimicrobial peptide penaeidin database: Sequence-based classification and recommended nomenclature. Dev Comp Immunol 2006,30(3),283-288","journal-title":"Dev Comp Immunol"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.rinim.2012.02.001","volume":"2","author":"Vaseeharan B.","year":"2012","unstructured":"Vaseeharan B.; Shanthi S.; Chen J-C.; Espineira M.; Molecular cloning, sequence analysis and expression of fein-penaeidin from the haemocytes of Indian white shrimp Fenneropenaeus indicus. Results Immunol 2012,2,35-43","journal-title":"Results Immunol"},{"key":"ref=147","author":"Xiao B.","year":"2018","unstructured":"Xiao B.; Fu Q.; Niu S.; Li H.; Lu K.; Wang S.; Yin B.; Weng S.; Li C.; He J.; Penaeidins are a novel family of antiviral effectors against wssv in shrimp. bioRxiv 2018","journal-title":"bioRxiv"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.cbpb.2011.10.006","volume":"161","author":"Cai L.","year":"2012","unstructured":"Cai L.; Cai J.; Liu H.; Fan D.; Peng H.; Wang K.; Comparative biochemistry and physiology, part b recombinant medaka (Oryzias melastigmus) pro-hepcidin: Multifunctional characterization. Comp Biochem Physiol Part B 2012,161(2),140-147","journal-title":"Comp Biochem Physiol Part B"},{"key":"ref=149","author":"Jiang Y.","unstructured":"Jiang Y.; Yang D.; Li W.; Wang B.; Jiang Z.; Li M.; Original article antiviral activity of recombinant mouse b -defensin 3 against influenza a virus in vitro and in vivo 2012, 262, 255-262","journal-title":"Original article antiviral activity of recombinant mouse b -defensin 3 against influenza a virus in vitro and in vivo 2012, 262, 255-262"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0924-8579(03)00201-2","volume":"22","author":"Pag&#xE8;s J-M.","year":"2003","unstructured":"Pag&#xE8;s J-M.; Dimarcq J-L.; Quenin S.; Hetru C.; Thanatin activity on multidrug resistant clinical isolates of Enterobacter aerogenes and Klebsiella pneumoniae. Int J Antimicrob Agents 2003,22(3),265-269","journal-title":"Int J Antimicrob Agents"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-18102-6","volume":"7","author":"Sinha S.","year":"2017","unstructured":"Sinha S.; Zheng L.; Mu Y.; Ng W.J.; Bhattacharjya S.; Structure and interactions of a host defense antimicrobial peptide thanatin in lipopolysaccharide micelles reveal mechanism of bacterial cell agglutination. Sci Rep 2017,7(1),1-13","journal-title":"Sci Rep"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"Article number 180","DOI":"10.1186\/s13568-018-0710-4","volume":"8","author":"Mamarabadi M.","year":"2018","unstructured":"Mamarabadi M.; Tanhaeian A.; Ramezany Y.; Antifungal activity of recombinant thanatin in comparison with two plant extracts and a chemical mixture to control fungal plant pathogens. AMB Express 2018,8(1),Article number 180","journal-title":"AMB Express"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1073\/pnas.93.3.1221","volume":"93","author":"Fehlbaum P.","year":"1996","unstructured":"Fehlbaum P.; Bulet P.; Chernysh S.; Briand J-P.; Roussel J-P.; Letellier L.; Hetru C.; Hoffmann J.A.; Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc Natl Acad Sci USA 1996,93(3),1221-1225","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1007\/s12602-019-09539-4","volume":"11","author":"Sabokkhiz M.A.","year":"2019","unstructured":"Sabokkhiz M.A.; Tanhaeian A.; Mamarabadi M.; Study on antiviral activity of two recombinant antimicrobial peptides against tobacco mosaic virus. Probiotics Antimicrob Proteins 2019,11,1370-1378","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s00018-005-4560-2","volume":"62","author":"Papo N.","year":"2005","unstructured":"Papo N.; Shai Y.; Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci C 2005,62(7-8),784-790","journal-title":"Cell Mol Life Sci C"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1111\/j.1742-4658.2009.07360.x","volume":"276","author":"Auvynet C.","year":"2009","unstructured":"Auvynet C.; Rosenstein Y.; Multifunctional host defense peptides: Antimicrobial peptides, the small yet big players in innate and adaptive immunity. FEBS J 2009,276(22),6497-6508","journal-title":"FEBS J"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0966-842X(00)01823-0","volume":"8","author":"Hancock R.E.W.","year":"2000","unstructured":"Hancock R.E.W.; Diamond G.; The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 2000,8(9),402-410","journal-title":"Trends Microbiol"},{"key":"ref=158","author":"Ahmad B.","year":"2019","unstructured":"Ahmad B.; Hanif Q.; Xubiao W.; Lulu Z.; Shahid M.; Expression and purification of hybrid ll-37t &#x3B1; 1 peptide in Pichia pastoris and evaluation of its immunomodulatory and anti-inflammatory activities by lps neutralization 10, 1-12.2019","journal-title":"Expression and purification of hybrid ll-37t &#x3B1; 1 peptide in Pichia pastoris and evaluation of its immunomodulatory and anti-inflammatory activities by lps neutralization"},{"key":"ref=159","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1021\/bi2016266","volume":"51","author":"Wang G.","year":"2012","unstructured":"Wang G.; Elliott M.; Cogen A.L.; Ezell E.L.; Gallo R.L.; Hancock R.E.W.; Structure, dynamics, and antimicrobial and immune modulatory activities of human ll-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins. Biochemistry 2012,51(2),653-664","journal-title":"Biochemistry"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/ATVBAHA.111.222745","volume":"31","author":"Baitsch D.","year":"2011","unstructured":"Baitsch D.; Bock H.H.; Engel T.; Telgmann R.; M&#xFC;ller-Tidow C.; Varga G.; Bot M.; Herz J.; Robenek H.; Von Eckardstein A.; Nofer J.R.; Apolipoprotein E.; Induces antiinflammatory phenotype in macrophages. Arterioscler Thromb Vasc Biol 2011,31(5),1160-1168","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1046\/j.1365-2567.2003.01665.x","volume":"109","author":"Tenger C.","year":"2003","unstructured":"Tenger C.; Zhou X.; Apolipoprotein E.; Modulates immune activation by acting on the antigen-presenting cell. Immunology 2003,109(3),392-397","journal-title":"Immunology"},{"key":"ref=162","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.4049\/jimmunol.133.3.1379","volume":"133","author":"Curtiss L.K.","year":"1984","unstructured":"Curtiss L.K.; Forte T.M.; Davis P.A.; Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation. J Immunol 1984,133(3),1379-1384","journal-title":"J Immunol"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1074\/jbc.272.1.89","volume":"272","author":"Riddell D.R.","year":"1997","unstructured":"Riddell D.R.; Graham A.; Owen J.S.; Apolipoprotein E.; Inhibits platelet aggregation through the l-arginine: Nitric oxide pathway implications for vascular disease. J Biol Chem 1997,272(1),89-95","journal-title":"J Biol Chem"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/nature04001","volume":"437","author":"Van Den Elzen P.","year":"2005","unstructured":"Van Den Elzen P.; Garg S.; Le&#xF3;n L.; Brigl M.; Leadbetter E.A.; Gumperz J.E.; Dascher C.C.; Cheng T-Y.; Sacks F.M.; Illarionov P.A.; Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 2005,437(7060),906-910","journal-title":"Nature"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/S0022-2275(20)32160-X","volume":"39","author":"Roselaar S.E.","year":"1998","unstructured":"Roselaar S.E.; Daugherty A.; Apolipoprotein e-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J Lipid Res 1998,39(9),1740-1743","journal-title":"J Lipid Res"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0022-2275(20)32147-7","volume":"40","author":"de Bont N.","year":"1999","unstructured":"de Bont N.; Netea M.G.; Demacker P.N.M.; Verschueren I.; Kullberg B.J.; van Dijk K.W.; van der Meer J.W.M.; Stalenhoef A.F.H.; Apolipoprotein E.; Knock-out mice are highly susceptible to endotoxemia and Klebsiella pneumoniae infection. J Lipid Res 1999,40(4),680-685","journal-title":"J Lipid Res"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1111\/febs.13725]","volume":"283","author":"Pane K.","year":"2016","unstructured":"Pane K.; Sgambati V.; Zanfardino A.; Smaldone G.; Cafaro V.; Angrisano T.; Pedone E.; Gaetano S.; Di; Capasso, D.; Haney, E. F.; Izzo, V.; Varcamonti, M.; Notomista, E.; Hancock, R. E. W.; Donato, A. D.; Pizzo, E. A new cryptic cationic antimicrobial peptide from human apolipoprotein E with antibacterial activity and immunomodulatory effects on human cells. FEBS J 2016,283,2115-2131","journal-title":"FEBS J"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3748\/wjg.v24.i6.706","volume":"24","author":"Xu C.","year":"2018","unstructured":"Xu C.; Guo Y.; Qiao L.; Ma L.; Cheng Y.; Recombinant expressed vasoactive intestinal peptide analogue ameliorates tnbs-induced colitis in rats. World J Gastroenterol 2018,24(6),706-715","journal-title":"World J Gastroenterol"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s0140-6736(10)60577-6","volume":"376","author":"Snow R.W.","year":"2010","unstructured":"Snow R.W.; Marsh K.; Malaria in africa: Progress and prospects in the decade since the Abuja declaration. Lancet 2010,376(9735),137-139","journal-title":"Lancet"},{"key":"ref=170","unstructured":"World malaria report 2019, 2019 Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241565721","journal-title":"World malaria report 2019, 2019 Available from:"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nrmicro2331","volume":"8","author":"Dondorp A.M.","year":"2010","unstructured":"Dondorp A.M.; Yeung S.; White L.; Nguon C.; Day N.P.J.; Socheat D.; Von Seidlein L.; Artemisinin resistance: Current status and scenarios for containment. Nat Rev Microbiol 2010,8(4),272-280","journal-title":"Nat Rev Microbiol"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.2174\/138161211797416057","volume":"17","author":"Bell A.","year":"2011","unstructured":"Bell A.; Antimalarial peptides: The long and the short of it. Curr Pharm Des 2011,17(25),2719-2731","journal-title":"Curr Pharm Des"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.febslet.2004.07.019","volume":"572","author":"Choi S.J.","year":"2004","unstructured":"Choi S.J.; Parent R.; Guillaume C.; Deregnaucourt C.; Delarbre C.; Ojcius D.M.; Montagne J.J.; C&#xE9;l&#xE9;rier M.L.; Phelipot A.; Amiche M.; Isolation and characterization of psalmopeotoxin I and II: Two novel antimalarial peptides from the venom of the tarantula Psalmopoeus cambridgei. FEBS Lett 2004,572(1\u20133),109-117","journal-title":"FEBS Lett"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1007\/s00018-008-8250-8","volume":"65","author":"Carballar-Lejaraz&#xFA; R.","year":"2008","unstructured":"Carballar-Lejaraz&#xFA; R.; Rodr&#xED;guez M.H.; De La Cruz Hern&#xE1;ndez-Hern&#xE1;ndez F.; Ramos-Casta&#xF1;eda J.; Possani L.D.; Zurita-Ortega M.; Reynaud-Garza E.; Hern&#xE1;ndez-Rivas R.; Loukeris T.; Lycett G.; Recombinant scorpine: A multifunctional antimicrobial peptide with activity against different pathogens. Cell Mol Life Sci 2008,65(19),3081-3092","journal-title":"Cell Mol Life Sci"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbamem.2007.11.008","volume":"1778","author":"Hoskin D.W.","year":"2008","unstructured":"Hoskin D.W.; Ramamoorthy A.; Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys. Acta (BBA)-. Biomembranes 2008,1778(2),357-375","journal-title":"Biomembranes"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.chemphyslip.2011.09.004","volume":"164","author":"Riedl S.","year":"2011","unstructured":"Riedl S.; Zweytick D.; Lohner K.; Membrane-active host defense peptides-challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids 2011,164(8),766-781","journal-title":"Chem Phys Lipids"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0005-2736(99)00201-1","volume":"1462","author":"Dathe M.","year":"1999","unstructured":"Dathe M.; Wieprecht T.; Structural features of helical antimicrobial peptides: Their potential to modulate activity on model membranes and biological cells. Biochim. Biophys. Acta (BBA)-. Biomembranes 1999,1462(1\u20132),71-87","journal-title":"Biomembranes"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/1386207053764576","volume":"8","author":"Lohner K.","year":"2005","unstructured":"Lohner K.; Blondelle S.E.; Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. Comb Chem High Throughput Screen 2005,8(3),241-256","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.tibtech.2008.01.002","volume":"26","author":"Bhutia S.K.","year":"2008","unstructured":"Bhutia S.K.; Maiti T.K.; Targeting tumors with peptides from natural sources. Trends Biotechnol 2008,26(4),210-217","journal-title":"Trends Biotechnol"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1471-2164-8-119","volume":"8","author":"Schwartz E.F.","year":"2007","unstructured":"Schwartz E.F.; Diego-Garcia E.; de la Vega R.C.R.; Possani L.D.; Transcriptome analysis of the venom gland of the mexican scorpion Hadrurus gertschi (arachnida: Scorpiones). BMC Genomics 2007,8(1),119","journal-title":"BMC Genomics"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.3892\/etm.2016.3578","volume":"12","author":"Xing L.W.","year":"2016","unstructured":"Xing L.W.; Tian S.X.; Gao W.; Yang N.; Qu P.; Liu D.; Jiao J.; Wang J.; Feng X.J.; Recombinant expression and biological characterization of the antimicrobial peptide fowlicidin-2 in Pichia pastoris. Exp Ther Med 2016,12(4),2324-2330","journal-title":"Exp Ther Med"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/10826068.2014.979206","volume":"46","author":"Fan K.","year":"2016","unstructured":"Fan K.; Li H.; Wang Z.; Du W.; Yin W.; Sun Y.; Jiang J.; Expression and purification of the recombinant porcine nk-lysin in Pichia pastoris and observation of anticancer activity in vitro. Prep Biochem Biotechnol 2016,46(1),65-70","journal-title":"Prep Biochem Biotechnol"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.7150\/thno.16425","volume":"6","author":"Sarangthem V.","year":"2016","unstructured":"Sarangthem V.; Kim Y.; Singh T.D.; Seo B.Y.; Cheon S.H.; Lee Y.J.; Lee B.H.; Park R.W.; Multivalent targeting based delivery of therapeutic peptide using ap1-elp carrier for effective cancer therapy. Theranostics 2016,6(12),2235-2249","journal-title":"Theranostics"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.3892\/or.2016.4570]","volume":"35","author":"Sun M.","year":"2016","unstructured":"Sun M.; Tang H.; Gao Y.; Dai X.; Yuan Y.; Zhang C.; Sun D.; Constitutive expression and anticancer potency of a novel immunotoxin onconase-DV3. Oncol Rep 2016,35(4),1987-1994","journal-title":"Oncol Rep"},{"key":"ref=185","first-page":"124","volume":"11","author":"Golias C.","year":"2007","unstructured":"Golias C.; Charalabopoulos A.; Stagikas D.; Charalabopoulos K.; Batistatou A.; The kinin system-bradykinin: Biological effects and clinical implications. Multiple role of the kinin system-bradykinin. Hippokratia 2007,11(3),124","journal-title":"Hippokratia"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.toxicon.2011.07.013","volume":"59","author":"Camargo A.C.M.","year":"2012","unstructured":"Camargo A.C.M.; Ianzer D.; Guerreiro J.R.; Serrano S.M.T.; Bradykinin-potentiating peptides: Beyond captopril. Toxicon 2012,59(4),516-523","journal-title":"Toxicon"},{"key":"ref=187","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-015-0394-2","author":"Yang G.","unstructured":"Yang G.; Jiang Y.; Yang W.; Du F.; Yao Y.; Shi C.; Wang C.; Effective treatment of hypertension by recombinant Lactobacillus plantarum expressing angiotensin converting enzyme inhibitory peptide Microb Cell Fact, 2015, Article number: 202, 1-9","journal-title":"Effective treatment of hypertension by recombinant Lactobacillus plantarum expressing angiotensin converting enzyme inhibitory peptide Microb Cell Fact, 2015, Article number: 202, 1-9"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1002\/biot.200700092","volume":"2","author":"Losacco M.","year":"2007","unstructured":"Losacco M.; Gallerani R.; Gobbetti M.; Minervini F.; De Leo F.; Prodution of active angiotensin-i converting enzyme inhibitory peptides derived from bovine &#x3B2;-casein by recombinant DNA technologies. Biotechnol J 2007,2(11),1425-1434","journal-title":"Biotechnol J"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1021\/jf0703248","volume":"55","author":"Liu D.","year":"2007","unstructured":"Liu D.; Sun H.; Zhang L.; Li S.; High-level expression of milk-derived antihypertensive peptide in Escherichia coli and its bioactivity. J Agric Food Chem 2007,55(13),5109-5112","journal-title":"J Agric Food Chem"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.4014\/jmb.0905.05055","volume":"19","author":"Rao S.","year":"2009","unstructured":"Rao S.; Su Y.; Li J.; Xu Z.; Yang Y.; Design and expression of recombinant antihypertensive peptide multimer gene in Escherichia coli bl21. J Microbiol Biotechnol 2009,19(12),1620-1627","journal-title":"J Microbiol Biotechnol"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2174\/092986611795446067","volume":"18","author":"Rao S.","year":"2011","unstructured":"Rao S.; Xu Z.; Su Y.; Li J.; Sun J.; Yang Y.; Cloning, soluble expression, and production of recombinant antihypertensive peptide multimer (ahpm-2) in Escherichia coli for bioactivity identification. Protein Pept Lett 2011,18(7),699-706","journal-title":"Protein Pept Lett"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"7915","DOI":"10.1073\/pnas.90.17.7915","volume":"90","author":"Ames B.N.","year":"1993","unstructured":"Ames B.N.; Shigenaga M.K.; Hagen T.M.; Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993,90(17),7915-7922","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0300-483X(00)00210-9","volume":"148","author":"Bagchi D.","year":"2000","unstructured":"Bagchi D.; Bagchi M.; Stohs S.J.; Das D.K.; Ray S.D.; Kuszynski C.A.; Joshi S.S.; Pruess H.G.; Free radicals and grape seed proanthocyanidin extract: Importance in human health and disease prevention. Toxicology 2000,148(2\u20133),187-197","journal-title":"Toxicology"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"662","DOI":"10.5897\/JMPR11.517","volume":"6","author":"Phadungkit M.","year":"2012","unstructured":"Phadungkit M.; Somdee T.; Kangsadalampai K.; Phytochemical screening, antioxidant and antimutagenic activities of selected thai edible plant extracts. J Med Plants Res 2012,6(5),662-666","journal-title":"J Med Plants Res"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"435","DOI":"10.12691\/jfnr-2-8-2","volume":"2","author":"Lin K.","year":"2014","unstructured":"Lin K.; Yeh H.; Lin S.; Yang C.; Tsai S.; Tsai J.; Chao P-Y.; Antioxidant activities of methanol extracts from selected Taiwanese herbaceous plants. J Food Nutr Res 2014,2(8),435-442","journal-title":"J Food Nutr Res"},{"key":"ref=196","first-page":"329","volume":"196","author":"Kahl R.","year":"1993","unstructured":"Kahl R.; Kappus H.; Toxicology of the synthetic antioxidants bha and bht in comparison with the natural antioxidant vitamin E. Zeitschrift fur Leb. Und-forsch 1993,196(4),329-338","journal-title":"Und-forsch"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0924-2244(00)89112-8","volume":"6","author":"Madsen H.L.","year":"1995","unstructured":"Madsen H.L.; Bertelsen G.; Spices as antioxidants. Trends Food Sci Technol 1995,6(8),271-277","journal-title":"Trends Food Sci Technol"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.foodres.2012.08.023","volume":"49","author":"He R.","year":"2012","unstructured":"He R.; Ju X.; Yuan J.; Wang L.; Girgih A.T.; Aluko R.E.; Antioxidant activities of rapeseed peptides produced by solid state fermentation. Food Res Int 2012,49(1),432-438","journal-title":"Food Res Int"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.procbio.2014.07.002","volume":"49","author":"Wang Y.","year":"2014","unstructured":"Wang Y.; Chen H.; Wang J.; Xing L.; Preparation of active corn peptides from zein through double enzymes immobilized with calcium alginate-chitosan beads. Process Biochem 2014,49(10),1682-1690","journal-title":"Process Biochem"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.foodchem.2015.02.046","volume":"180","author":"Torres-Fuentes C.","year":"2015","unstructured":"Torres-Fuentes C.; del Mar Contreras M.; Recio I.; Alaiz M.; Vioque J.; Identification and characterization of antioxidant peptides from chickpea protein hydrolysates. Food Chem 2015,180,194-202","journal-title":"Food Chem"},{"key":"ref=201","first-page":"40","author":"Wichai T.","year":"2018","unstructured":"Wichai T.; Boonsombat R.; Bioactive activity of a recombinant longan (Dimocarpus longan lour.) seed peptide. Proc Int Conf Appl Sci Health 2018,40-46","journal-title":"Proc Int Conf Appl Sci Health"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1007\/s11033-018-4468-1","volume":"46","author":"Ahmadi-Vavsari F.","year":"2019","unstructured":"Ahmadi-Vavsari F.; Farmani J.; Dehestani A.; Recombinant production of a bioactive peptide from spotless smooth-hound (Mustelus griseus) muscle and characterization of its antioxidant activity. Mol Biol Rep 2019,46(3),2599-2608","journal-title":"Mol Biol Rep"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1007\/s13197-018-3365-x","volume":"55","author":"Wu Y.","year":"2018","unstructured":"Wu Y.; Ma Y.; Li L.; Yang X.; Molecular modification, expression and purification of new subtype antioxidant peptide from Pinctada fucata by recombinant Escherichia coli to improve antioxidant-activity. J Food Sci Technol 2018,55(10),4266-4275","journal-title":"J Food Sci Technol"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201022666210702123934","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/194439\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201022666210702123934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T23:58:33Z","timestamp":1672703913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/194439\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":203,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201022666210702123934","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}